LIFEVANTAGE CORP Contract with Customer, Refund Liability
LIFEVANTAGE CORP (LFVN) had Contract with Customer, Refund Liability of $300.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-05.
Discontinued › Notes
us-gaap:ContractWithCustomerRefundLiability · last filed 2020-05-05
- 2020-03-31: Contract with Customer, Refund Liability $300.00K.
- 2019-12-31: Contract with Customer, Refund Liability $300.00K.
- 2019-09-30: Contract with Customer, Refund Liability $300.00K.
- 2019-06-30: Contract with Customer, Refund Liability $400.00K.
| Period end | Contract with Customer, Refund Liability |
|---|---|
| 2020-03-31 | $300.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $300.00K 10-Q · filed 2020-01-28 |
| 2019-09-30 | $300.00K 10-Q · filed 2019-10-30 |
| 2019-06-30 | $400.00K 10-Q · filed 2020-05-05 |
| 2019-03-31 | $300.00K 10-Q · filed 2019-05-01 |
| 2018-12-31 | $300.00K 10-Q · filed 2019-02-04 |
| 2018-09-30 | $300.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $400.00K 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |